Showing 601-610 of 3200 results for "".
A Multidisciplinary Toolbox for Atopic Dermatitis Treatments
https://practicaldermatology.com/topics/atopic-dermatitis/a-multidisciplinary-toolbox-for-atopic-dermatitis-treatments/23445/Efficacy and Safety of Newly Approved Oral Sarecycline for Acne
https://practicaldermatology.com/columns/clinical-focus-1/efficacy-and-safety-of-newly-approved-oral-sarecycline-for-acne/22996/A closer look at the first NCE approved to treat acne in more than a decade.When Topicals Fail: The New IPC Consensus Every Clinician Should Know
https://practicaldermatology.com/programs/cme/when-topicals-fail-the-new-ipc-consensus-every-clinician-should-know/39967/Review IPC’s 2025 consensus guidance on reclassifying psoriasis severity and redefining failure of topical therapies.Physician Dispensing: 7 Things Doctors Need to Know
https://practicaldermatology.com/topics/practice-management/physician-dispensing-7-things-doctors-need-to-know/23350/Physician dispensing provides a service to the patient while enhancing the practice. Here’s what you need to know.How to Use ChatGPT to Create a Social Media Content Calendar for Your Practice
https://practicaldermatology.com/topics/practice-management/how-to-use-chatgpt-to-create-a-social-media-content-calendar-for-your-practice/23968/ChatGPT can help you ideate content and post it with consistency.Update on TB Screening Prior To and During Biologic Treatment
https://practicaldermatology.com/columns/clinical-focus-1/update-on-tb-screening-prior-to-and-during-biologic-treatment/23220/Is annual screening in all patients really neccesary?In the Pipeline: Clinical Trials
https://practicaldermatology.com/issues/october-2025/in-the-pipeline-clinical-trials/39765/Highlighting some of the clinical studies that began in 2025 for atopic dermatitis (AD) treatments.Fighting for Coverage: Combatting Private Insurance to Get Patients the Drugs They Need
https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/Aside from decreasing reimbursement rates, obtaining prior authorization from private insurance for medications that our patients desperately need to improve their lives, improve their skin conditions, and improve their wellbeing is probably the greatest challenge that dermatologists face today.Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Pearls for Monitoring and Managing Itch: An Expert Panel
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-for-monitoring-and-managing-itch-an-expert-panel/27172/A three-person panel covered the topic of itch recently at The Dermatology Education Foundation’s DEF Essential Resource Meeting 2024 (DERM2024) NP/PA CME Conference in Las Vegas, Nevada, with David Cohen, MD, MPH, leading “How to Avoid Doctor Strange: Pearls for Monitoring and Managing Itch.” Dr. C